Trade Vir Biotechnology VIR

VirBiotechnology live chart

instrument_fundamentals

Weekly Search
Weekly
Daily
date Close change Change (%) instr__open High Low

instr__news

Webhose 2025 Jun 04, 00:39

Insider Selling: Vir Biotechnology, Inc. (NASDAQ:VIR) Director Sells 3,200 Shares of Stock

Vir Biotechnology Inc
Webhose 2025 Jun 03, 07:38

Nuveen Asset Management LLC Has $2.64 Million Holdings in Vir Biotechnology, Inc. (NASDAQ:VIR)

Vir Biotechnology Inc
Webhose 2025 Jun 02, 00:00

Vir Biotechnology Inc. (VIR) - Insider Monkey

Vir Biotechnology Inc
Webhose 2025 May 31, 16:48

Vir Biotechnology (NASDAQ:VIR) Stock Price Down 7.6% - Here's What Happened

Vir Biotechnology Inc
Webhose 2025 May 30, 18:08

Vir Biotechnology (NASDAQ:VIR) Trading 6.6% Higher - What's Next?

Vir Biotechnology Inc

VirBiotechnology news

Latest news

Show more
Frances Wang 2025 Jun 26, 16:00

Stock market today: Sensex jumps, Nifty above 25,600, Dow and S&P 500 rise

Stocks
Frances Wang 2025 Jun 26, 16:00

XRP News Today: Ripple Price Slides 5%

Cryptocurrencies
Frances Wang 2025 Jun 25, 16:00

Stock Mover Today: Why BAC Stock Is Trending Now?

Stocks
Frances Wang 2025 Jun 25, 16:00

MSTR Stock News: MSTR Shares Rise 1.9% Amid Mixed Options Market Sentiment

Stocks
Ghko B 2025 Jun 25, 16:00

Stock indexes today: Dow Jumps 500 Points, S&P 500 Rises on Trump Ceasefire

Stocks
Frances Wang 2025 Jun 24, 16:00

Value of bitcoin today: BTC/USD over 106K as Middle East tensions eased

Cryptocurrencies
Frances Wang 2025 Jun 24, 16:00

Market movers today: Carnival, Tesla, Mastercard, SOFI

Stocks
Tommy Yap 2025 Jun 24, 16:00

Morning Note: Ceasefire Boosts Markets; Dovish Fed & RBA Rate Cut Bets Emerge

Morning Note Stocks Forex

Info

Spread

0.06

Spread (%)

1.1407 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Monday

13:31 - 19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Friday

13:31-19:59

instr__analysis_statistics

instr__open

---

instr__close

---

instr__52week_range

--- – ---

instr__market_cap

734755264

instr__shares_outstand

138238000

instr__earnings_date

0000-00-00

instr__dividend_date

instr__ex_dividend_date

instr__forward_annual_dividend_rate

0

instr__forward_annual_dividend_yield

0

instr__eps

-4.23

instrument_learn_more

Vir Biotechnology Vir Biotechnology Inc
Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors.The company's preclinical candidates include those targeting influenza A and B, coronavirus disease 2019, respiratory syncytial virus (RSV) and human metapneumovirus (MPV), and human papillomavirus (HPV). It has grant agreements with Gates Foundation; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with MedImmune, LLC; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A, as well as license agreement with Sanofi for three clinical-stage masked T-cell engagers (TCEs) and exclusive use of the protease-cleavable masking platform for oncology and infectious diseases. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.
Markets.com Bonus Trading

related_instruments

view_all_instruments

latest_education_articles

Show more
Trustpilot